TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT00003534

Antineoplaston Therapy in Treating Patients With Refractory Stage IV Prostate Cancer

Cause of deathSlow enrollment Automatic label, confidence 0.9, unverified. How labels are made.
“No participants enrolled.”

The sponsor’s own words in the registry.

Life of this trial

199619982000200220042006200820102012201420162018Planned start1996-10-11 (planned)Registered1999-11-01Withdrawn (as of)2018-01-31

Vital statistics

Status
Withdrawn
Phase
Phase 2
Sponsor
Burzynski Research Institute
Sponsor type
University, hospital or other
Conditions
Stage IV Prostate Cancer
Interventions
Antineoplaston therapy (Atengenal + Astugenal)
Participants
0
Sites
1
Countries
United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.